DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 937 filers reported holding DANAHER CORPORATION in Q4 2014. The put-call ratio across all filers is 0.82 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $129,149,779 | +3.0% | 587,258 | +12.1% | 0.98% | +6.2% |
Q2 2023 | $125,390,544 | -7.1% | 523,720 | -2.7% | 0.92% | -13.0% |
Q1 2023 | $134,970,967 | -6.3% | 538,375 | -1.0% | 1.06% | -10.0% |
Q4 2022 | $143,981,000 | +1.9% | 543,926 | -0.6% | 1.18% | -4.2% |
Q3 2022 | $141,259,000 | +0.5% | 547,325 | -1.6% | 1.23% | +6.7% |
Q2 2022 | $140,505,000 | -14.8% | 556,176 | -1.2% | 1.15% | +2.1% |
Q1 2022 | $164,899,000 | -10.8% | 562,890 | +0.2% | 1.13% | -7.2% |
Q4 2021 | $184,766,000 | +4.8% | 561,582 | -3.0% | 1.21% | -2.5% |
Q3 2021 | $176,264,000 | +19.5% | 578,953 | +5.3% | 1.24% | +9.9% |
Q2 2021 | $147,503,000 | +12.8% | 549,644 | -5.4% | 1.13% | -7.7% |
Q1 2021 | $130,738,000 | +1.0% | 580,849 | -0.4% | 1.23% | -3.5% |
Q4 2020 | $129,486,000 | -7.2% | 582,900 | -10.1% | 1.27% | -18.5% |
Q3 2020 | $139,593,000 | +21.1% | 648,275 | -0.5% | 1.56% | +11.2% |
Q2 2020 | $115,262,000 | +15.3% | 651,824 | -9.7% | 1.40% | -2.4% |
Q1 2020 | $99,926,000 | -10.4% | 721,954 | -0.7% | 1.44% | +20.5% |
Q4 2019 | $111,533,000 | +8.3% | 726,691 | +1.1% | 1.19% | -2.9% |
Q3 2019 | $102,968,000 | -1.2% | 718,931 | -1.4% | 1.23% | -1.0% |
Q2 2019 | $104,257,000 | +4.9% | 729,476 | -3.1% | 1.24% | +0.2% |
Q1 2019 | $99,414,000 | +27.1% | 753,021 | -0.7% | 1.24% | +15.0% |
Q4 2018 | $78,232,000 | -7.9% | 758,647 | -3.0% | 1.08% | +9.2% |
Q3 2018 | $84,969,000 | +10.0% | 781,968 | -0.1% | 0.99% | +3.5% |
Q2 2018 | $77,257,000 | -99.9% | 782,903 | -1.3% | 0.95% | -0.5% |
Q1 2018 | $77,690,577,000 | +4.6% | 793,490 | -0.8% | 0.96% | +7.5% |
Q4 2017 | $74,261,042,000 | +6.8% | 800,054 | -1.3% | 0.89% | +1.1% |
Q3 2017 | $69,510,299,000 | +0.9% | 810,332 | -0.7% | 0.88% | -3.2% |
Q2 2017 | $68,865,936,000 | +5.8% | 816,044 | -0.6% | 0.91% | -2.0% |
Q1 2017 | $65,107,592,000 | +101061.6% | 821,377 | -0.7% | 0.93% | +0.5% |
Q4 2016 | $64,360,000 | -99.9% | 826,834 | -0.7% | 0.92% | -4.0% |
Q3 2016 | $65,286,044,000 | -22.8% | 832,836 | -0.5% | 0.96% | -25.2% |
Q2 2016 | $84,553,899,000 | +6.1% | 837,167 | -0.4% | 1.29% | +3.0% |
Q1 2016 | $79,728,731,000 | +2.2% | 840,488 | +0.1% | 1.25% | -0.9% |
Q4 2015 | $78,011,547,000 | +10.2% | 839,918 | +1.1% | 1.26% | +6.1% |
Q3 2015 | $70,816,807,000 | +13.7% | 831,085 | +14.2% | 1.19% | +23.2% |
Q2 2015 | $62,303,849,000 | -0.5% | 727,933 | -1.3% | 0.97% | +0.4% |
Q1 2015 | $62,605,324,000 | -2.2% | 737,401 | -1.2% | 0.96% | -6.9% |
Q4 2014 | $63,992,290,000 | +11.4% | 746,614 | -1.3% | 1.03% | +3.0% |
Q3 2014 | $57,454,481,000 | -6.0% | 756,179 | -2.6% | 1.00% | -3.4% |
Q2 2014 | $61,108,931,000 | +4.1% | 776,184 | -0.8% | 1.04% | -2.4% |
Q1 2014 | $58,681,975,000 | -3.0% | 782,426 | -0.1% | 1.06% | -5.9% |
Q4 2013 | $60,469,990,000 | +11.0% | 783,290 | -0.3% | 1.13% | +0.6% |
Q3 2013 | $54,460,267,000 | +9.5% | 785,636 | +0.0% | 1.12% | +2.4% |
Q2 2013 | $49,725,021,000 | – | 785,545 | – | 1.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
Third Point | 2,900,000 | $954,129,000 | 6.66% |
Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |